ACM
ACT Capital Management Portfolio holdings
AUM
$72.5M
1-Year Return
33.17%
This Quarter Return
+20.54%
1 Year Return
-33.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$195M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
56.76%
Holding
117
New
117
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
STAAR Surgical
STAA
|
$35.3M |
| 2 |
Arrowhead Research
ARWR
|
$17.3M |
| 3 |
Arcturus Therapeutics
ARCT
|
$15.4M |
| 4 |
Clearside Biomedical
CLSD
|
$12M |
| 5 |
fuboTV
FUBO
|
$8.61M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 80.26% |
| 2 | Technology | 6.22% |
| 3 | Communication Services | 5.12% |
| 4 | Financials | 2.57% |
| 5 | Consumer Staples | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Immatics
IMTX
$658M
| $738K | 0.38% |
+63,500
| New | +$738K |
|
52
Enlivex Therapeutics
ENLV
$25M
| $735K | 0.38% |
+82,500
| New | +$735K |
|
53
NVIDIA
NVDA
$4.16T
| $721K | 0.37% |
+36,000
| New | +$721K |
|
|
GMBL
54
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
| $706K | 0.36% |
+2
| New | +$706K |
|
55
Amazon
AMZN
$2.49T
| $689K | 0.35% |
+4,000
| New | +$689K |
|
56
Coinbase
COIN
$78.6B
| $684K | 0.35% |
+2,700
| New | +$684K |
|
57
Cardiff Oncology
CRDF
$136M
| $682K | 0.35% |
+102,500
| New | +$682K |
|
58
Curis
CRIS
$22.5M
| $646K | 0.33% |
+4,000
| New | +$646K |
|
59
Rhythm Pharmaceuticals
RYTM
$6.85B
| $607K | 0.31% |
+31,000
| New | +$607K |
|
|
CKPT
60
DELISTED
Checkpoint Therapeutics
CKPT
| $605K | 0.31% |
+20,500
| New | +$605K |
|
61
PDS Biotechnology
PDSB
$54.6M
| $565K | 0.29% |
+45,000
| New | +$565K |
|
62
Teradata
TDC
$1.94B
| $550K | 0.28% |
+11,000
| New | +$550K |
|
|
OYST
63
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $542K | 0.28% |
+31,500
| New | +$542K |
|
64
Forte Biosciences
FBRX
$137M
| $541K | 0.28% |
+643
| New | +$541K |
|
|
CELL
65
DELISTED
PhenomeX Inc. Common Stock
CELL
| $538K | 0.28% |
+12,000
| New | +$538K |
|
66
Champions Oncology
CSBR
$92.4M
| $514K | 0.26% |
+50,000
| New | +$514K |
|
|
SIOX
67
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $506K | 0.26% |
+185,000
| New | +$506K |
|
|
AMPE
68
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $487K | 0.25% |
+972
| New | +$487K |
|
|
JMIA
69
Jumia Technologies
JMIA
$986M
| $440K | 0.23% |
+14,500
| New | +$440K |
|
|
AUD
70
DELISTED
Audacy, Inc.
AUD
| $421K | 0.22% |
+97,500
| New | +$421K |
|
71
Rocket Companies
RKT
$38.8B
| $420K | 0.22% |
+21,700
| New | +$420K |
|
72
Hillman Solutions
HLMN
$1.95B
| $403K | 0.21% |
+32,500
| New | +$403K |
|
|
MOGO
73
Mogo
MOGO
$42.1M
| $373K | 0.19% |
+15,833
| New | +$373K |
|
74
Affirm
AFRM
$29.4B
| $337K | 0.17% |
+5,000
| New | +$337K |
|
75
Arcutis Biotherapeutics
ARQT
$1.94B
| $328K | 0.17% |
+12,000
| New | +$328K |
|